NASDAQ: GANX - Gain Therapeutics, Inc.

六个月盈利: +47.28%
股息率: 0.00%
部门: Healthcare

促销时间表 Gain Therapeutics, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Gain Therapeutics, Inc.

Gain Therapeutics, Inc., a biotechnology company, researches and develops novel therapies to treat diseases caused by protein misfolding in Switzerland and Spain. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietary small molecules that bind these sites, restore protein folding, and treat disease. Its lead product candidate includes GT-02287, for the treatment of GBA1 Parkinson's disease.

更多详情
In addition, the company is developing structurally targeted allosteric regulator candidates to treat various diseases, including Morquio B, GM1 gangliosidosis (GM1), neuronopathic Gaucher disease, GBA1 Parkinson's, Krabbe, and Mucopolysaccharidosis type 1 diseases. Gain Therapeutics, Inc. was founded in 2017 and is headquartered in Bethesda, Maryland.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2021-03-18
ISIN US36269B1052
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.gaintherapeutics.com
Цена ао 3.8
每日价格变化: +10% (1.6)
每周价格变化: +12.82% (1.56)
每月价格变化: +1.15% (1.74)
3个月内价格变化: -11.56% (1.99)
六个月内的价格变化: +47.28% (1.195)
每年价格变化: -46.09% (3.265)
3年内价格变化: -67.88% (5.48)
5年内价格变化: 0% (1.76)
10年价格变化: 0% (1.76)
年初以来价格变化: +6.02% (1.66)
所有参数

低估

姓名 意义 年级
P/S 631.94 1
P/BV 2.77 6
P/E 0 0
EV/EBITDA -1.09 0
全部的: 3.5

效率

姓名 意义 年级
ROA, % -119.66 0
ROE, % -177.03 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.0359 10
全部的: 8

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 34.59 5
盈利能力 Ebitda, % 1008.48 10
盈利能力 EPS, % 357.22 10
全部的: 9
更多详情

机构 体积 分享, %
Greenlight Capital, Inc. 588410 3.63
Royal Bank of Canada 200248 1.23
Geode Capital Management, LLC 151476 0.93
CM Management, LLC 90000 0.55
Vanguard Group Inc 88385 0.54
Citadel Advisors Llc 65394 0.4
Prelude Capital Management LLC 58100 0.36
Bridgeway Capital Management, Inc. 46100 0.28
Northern Trust Corporation 43513 0.27
Renaissance Technologies, LLC 42800 0.26

ETF 分享, % 本年盈利能力, % 股息, %
iShares Micro-Cap ETF 0.00615 17.09 1.54048



导师 职称 支付 出生年份
Dr. Khalid Islam Ph.D. Executive Chairman 75k 1955 (70 年)
Dr. Joanne Taylor Ph.D. Senior Vice President of Research N/A
Dr. Terenzio Ignoni Pharm.D. Senior Vice President of Technical Operations N/A
Mr. Gene Mack M.B.A. CFO & Interim CEO N/A
Dr. Jonas Hannestad M.D., Ph.D. Chief Medical Officer N/A

地址: United States, Bethesda. MD, 4800 Montgomery Lane - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.gaintherapeutics.com